Sagara H, D'Andrea P, Tanase AM, Pethe A, et al. Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-wee J Asthma 2022 Mar 29:1-13. doi: 10.1080/02770903.2022.2056048.
PMID: 35348408